-transparent.png){kind=logo}
Point mutations of c-ras genes at codons 12, 13 and 61 were analyzed in 26 cases of bladder cancer and 16 cases of kidney cancer. DNA prepared from either frozen tissues or 10% formalin-fixed, paraffin-embedded tissues were amplified by means of polymerase chain reaction methods, and mutations were analyzed by dot blot hybridization assays with oligonucleotide probes. In three cases of bladder cancer c-ras mutations were found, at codons 13 and 61 of c-Ha-ras and at codon 61 of c-Ki-ras, while no mutation was found in kidney cancer. No mutation was found in normal bladder epithelial tissues from the same patients. Our findings, taken together, may indicate relative scarcity of c-ras mutations in these types of human cancer. The results of dot blot hybridization assays and DNA sequencing showed a G-to-C transition of the first nucleotide at codon 13 c-Ha-ras. This is the first time that such a point mutation has been detected in human cancer tissues.
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
January 1992,
Urological research,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
March 2001,
Cancer letters,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
May 1990,
Cancer letters,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
January 1994,
World journal of surgery,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
January 1993,
Neoplasma,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
August 1995,
Japanese journal of cancer research : Gann,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
September 1995,
International journal of oncology,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
May 1994,
British journal of urology,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
January 1998,
Toxicologic pathology,
Y Nagata, and
M Abe, and
K Kobayashi, and
S Saiki, and
T Kotake, and
K Yoshikawa, and
R Ueda, and
E Nakayama, and
H Shiku
June 1993,
Human molecular genetics,
